Status:
RECRUITING
Investigation of the Frequency of Hereditary Hyper Alpha-tryptasemia in Patients With Elevated Basal Tryptasemia
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Allergic Bronchiolitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of the study is to assess the number of patients with elevated blood tryptase for whom this elevation could be linked to a hereditary alpha-tryptase secretion abnormality or hyper-alpha-trypta...
Eligibility Criteria
Inclusion
- Patients who came in the pneumoallergology department of the CHU de Nice since January 2014 for an allergological workup
- Patients who have received at least one basal tryptase assay, according to recommendations
- informed consent signature
Exclusion
- High tryptasemia (≥ 8ng/ml) synchronous with anaphylactic reaction and unconfirmed basally
- Known diagnosis of systemic mastocytosis
Key Trial Info
Start Date :
December 5 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06133907
Start Date
December 5 2023
End Date
December 1 2026
Last Update
June 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nice - Hôpital de Pasteur
Nice, Alpes-Maritimes, France, 06001